Articles and Blogs

Whistleblowers

Constitutional Implications for FCA Actions: Federal Court Ruling Challenges the Future of Whistleblower Lawsuits in Health Care

[10/01/24]

Posted on October 1, 2024 in Health Law News, Litigation Analysis

Published by: Hall Render

The Federal District Court for the Middle District of Florida (“the Court”) in United States ex rel. Zafirov v. Florida Medical Associates, LLC et al., recently held that a relator’s role as set forth in the False Claims Act’s (“FCA”) qui tam provision is unconstitutional under Article II’s Appointments Clause and dismissed the case.... READ MORE

Tags: , , , ,

DOJ Announces $2.68 Billion in False Claims Act Recoveries

[02/23/24]

Posted on February 23, 2024 in False Claims Act Defense, Health Law News

Published by: Hall Render

On February 22, 2024, the Department of Justice (“DOJ”) announced that it recovered over $2.68 billion in False Claims Act (“FCA”) settlements and judgments during the 2023 federal fiscal year. Notably, this amount stems from the highest number of settlements and judgments in a single year, including 543 settlements and judgments during this last... READ MORE

Tags: , , , ,

Supreme Court Justices Issue Decision in SOX Retaliation Case

[02/14/24]

Posted on February 14, 2024 in Health Law News, HR Insights for Health Care

Published by: Hall Render

In the recent case of Murray v. UBS Securities LLC et al., the U.S. Supreme Court unanimously ruled that whistleblowers do not need to show retaliatory intent as part of a retaliation claim against an employer under the Sarbanes-Oxley Act (“SOX”), which governs corporate financial reporting and recordkeeping. The Supreme Court reinstated a $900,000... READ MORE

Tags: , , , ,

What You Should Know About Health Systems and the Attorney-Client Privilege

[03/21/22]

Posted on March 21, 2022 in False Claims Act Defense, Health Law News

Published by: Hall Render

A federal district court affirmed this guidance in a careful analysis of the attorney-client privilege and its application to protect separate legal entities within a larger corporate structure. Affirming that member entities are not treated as “one client,” the Court in U.S. ex rel Behnke v. CVS Caremark Corp., et al. denied a whistleblower’s... READ MORE

Tags: , , , , ,

DOJ Recouped $5.6 Billion Under FCA in 2021

[02/04/22]

Posted on February 4, 2022 in False Claims Act Defense, Health Law News

Published by: Hall Render

Earlier this week, the Department of Justice (“DOJ”) announced that the United States recovered over $5.6 billion from False Claims Act (“FCA”) cases in the federal fiscal year 2021, “the second largest annual total in False Claims Act history” and more than doubling the FCA recoveries for the DOJ from fiscal year 2020. Of... READ MORE

Tags: , , , ,

Supreme Court Extends the FCA Statute of Limitations for Whistleblowers

[05/20/19]

Posted on May 20, 2019 in False Claims Act Defense

Published by: Hall Render

This week, the United States Supreme Court ruled that the government’s 10-year deadline to file FCA actions could be extended to whistleblowers. The Court’s decision in Cochise Consultancy, Inc. et al. v. United States ex rel. Hunt[1] resolved a circuit split that had dogged the courts, whistleblowers and defendants for decades. Health care providers... READ MORE

Tags: , , ,